ASGR1 and hepatocellular carcinoma: Three candidate antibodies—anti‐EpCAM, anti‐ASGPR, and anti‐GPC‐3—were selected to target these specific surface markers, aiming to achieve the desired sensitivity and specificity for HCC CTC identification.